Similar Articles |
|
Managed Care March 2006 |
Study: No Need To Burden Consumers To Cut Drug Bill A study by Express Scripts shows that changing the prescription benefit copayments can reduce costs by encouraging more use of generic drugs. All without shifting costs to consumers. |
Managed Care January 2008 |
Copayment Rates Outpace Inflation Workers are definitely paying more for health benefits today than they were in 2000, especially for prescription drug copayments. |
Managed Care January 2005 |
Generic Prescription Fill Rates Vary Widely Across the Country Use of generic medications continues to increase, but the generic fill rate varies widely across the country, with possible explanations including variations in prescribing patterns, state regulations, etc. |
Managed Care January 2008 |
Utilization Slowed by Switch From Copayment to Coinsurance Switching from a copayment benefit design to a coinsurance benefit design slowed the growth of total per-member per-month (PMPM) expenditures for all drug classes but did not have a significant effect on overall PMPM utilization. |
Managed Care November 2006 |
The Formulary Files Step therapy for antidepressants saves 11.7 percent in one year. |
The Motley Fool August 5, 2004 Tim Beyers |
Will Lawsuit Hurt Express Scripts? Although investors seem to be over the initial jitters arising from Express Scripts' problems, the stock is still down more than 12% since New York Attorney General Eliot Spitzer filed a lawsuit accusing the pharmacy benefits manager of fraud. |
The Motley Fool August 1, 2008 Brian Orelli |
Express Scripts Gets More Generic Pharmacy benefits manager Express Scripts may not have grown the top line by much in the second quarter, but using more generic drugs had a positive effect on the bottom line. |
Managed Care July 2002 Thomas Kaye |
Managing the Drug Benefit: One Company's Experience The pharmacy director of Blue Cross of Oklahoma shares his company's success with using three tiers and coinsurance to promote member responsibility. |
Managed Care January 2001 |
Express Scripts' Formulary Rulings To Go Online The public will have a chance to see what until now has been, mostly, understood only by managed care insiders: how a prescription drug winds up on a formulary... |
Managed Care May 2001 |
Old Ideas About Formulary Structure Gone as Humana Tests 4-Tier Model Humana is phasing in a four-tier formulary that categorizes prescription drugs by costs, rather than generic or brand status. The higher the drug's acquisition cost -- regardless of whether it's a branded or generic product -- the higher the tier it lands in... |
Pharmaceutical Executive May 1, 2011 Mason Tenaglia |
Out of Control The pharmaceutical industry needs to use new and better data to accurately measure how much it is willing to invest in avoiding plan control. |
Managed Care November 2004 |
Tiered Formularies Open the Potential for Lack of Access to Needed Drugs Tiered formularies that have additional incentives for preferred medications could create the potential for therapeutic compromises. |
Military & Aerospace Electronics February 2006 |
Proximity sensors for aerospace, industrial, and other applications The PRX+2450 is an overmolded pick-and-place form of the HSR-0025 for applications where size and performance are critical. It combines switching and sensing functions in one tiny package. |
The Motley Fool January 13, 2009 Dayana Yochim |
Fiscal Fitness '09: 6 Ways to Score Cheap(er) Drugs Save more than $200 on prescriptions. |
Managed Care March 2001 |
Single-source drugs get formulary preference Managed care organizations often place costly new drugs on a formulary's priciest tier, but products for which substitutes do not exist often are made available at lower copayment levels... |
Managed Care January 2004 |
Increasing drug copayments deter compliance Raising copayments in tiered prescription drug plans increases the likelihood that patients will stop taking prescribed medications, according to a recent study published in the New England Journal of Medicine. |
The Motley Fool July 30, 2009 Brian Orelli |
A Good Business Model for Bad Times Some businesses benefit when people are hurting. It's a beautiful time to be a pharmacy benefit manager, since that business model essentially results in them making more money when their customers save money. |
InternetNews February 26, 2009 Sean Michael Kerner |
Cautious Optimism as Ethernet Switch Sales Slow Vendors raked in $18 billion in 2008, but signs point to waning growth heading into 2009. |
Managed Care August 2007 |
Incentive Formularies Have Minimal Effect A brief look at the effect of changes in drug benefit design on pharmaceutical use and spending. |
Managed Care August 2005 Abourjaily et al. |
Evaluating the Nondrug Costs of Formulary Coverage Restrictions Substantial nondrug costs result from switching prescribed medications in response to changes in insurance coverage, and many non-reimbursed costs shift to providers and patients. |
CRM February 2014 Robert Wollan |
Surviving and Thriving in a Switching Economy The $1.3 trillion "switching economy" is comprised of dissatisfied customers who are continually looking for new providers that can better address their changing needs. Here are five tips for retaining customers. |
Managed Care August 2004 Martin Sipkoff |
Bad Tiered Formulary Designs Yield Poor Outcomes, High Cost Now that tiered formularies rule the land, what many suspected is being demonstrated: Compliance is suffering and so, too, are patients. |
The Motley Fool January 12, 2010 Dayana Yochim |
6 Ways to Score Cheap(er) Drugs Stop overpaying for the pills you have to pop with these simple ways to trim your prescription-drug tab. |
Managed Care November 2004 Tony Berberabe |
Military Brings Order To Formulary System Congress told the Department of Defense to create a uniform formulary for all the services, and cover all FDA-approved drugs. |
Pharmaceutical Executive March 3, 2014 Mason Tenaglia |
The New Metrics of Market Success Profitability now depends on metrics to help companies answer a key strategic question: "stay the course" with more investment in sales and marketing? Or "stand down" and deploy those scarce assets somewhere else? |
InternetNews January 22, 2010 |
New Alcatel-Lucent Switch Hits 4Tb Mark New optical switch aimed at improving scalability as core traffic grows. |
The Motley Fool March 4, 2005 Tom Taulli |
In the Express Scripts Lane Express Scripts' strong results bring a much-needed lift to health-care investors. |
Military & Aerospace Electronics November 2004 Janesch & Ivons |
Choosing the Right Switch System Challenges Test Engineers Despite a variety of electronic systems, for all of them automation can improve them. An essential part of automated testing is a switching system, which routes signals between measurement instruments and the device under test (DUT). |
Managed Care September 2007 |
Income Said To Influence Use of Generics An observational analysis of pharmacy claims collected from 2001 to 2003 finds that where a person lives and the socioeconomic implications of that location have a lot do with his use of generic drugs. |
Managed Care March 2000 |
Three-tier drug copayments in; closed formularies on way out? |
The Motley Fool December 19, 2006 Matthew Crews |
Express Scripts' Takeover Battle The pharmacy benefits manager challenges CVS with a higher bid for rival Caremark RX. Investors, stay tuned -- this is far from over. |
Pharmaceutical Executive February 1, 2014 Jill Wechsler |
Drug Coverage, Costs Under Scrutiny Benefits offered by insurance plans on health exchanges and through Medicare are raising concerns about patient access to needed therapies |
CIO September 26, 2013 Stephanie Overby |
Big Data Project Cuts Prescription Costs Express Scripts analytics portal helps doctors prescribe more cost-effective medicines. |
The Motley Fool October 29, 2009 Brian Orelli |
Expressing Itself Nicely A nice quarter for Express Scripts. |
Managed Care February 2002 Bob Carlson |
Proposal To Regulate Formularies Draws Sharp Difference of Opinion The National Association of Insurance Commissioners has spent two years developing a model. Drug companies like it; health plans don't... |
Managed Care October 2004 Arthur Lazarus |
Formulary Restrictions Sometimes Harm Patients Much more research is needed to determine the full effect of drug benefit designs. Quality must be the foremost concern. |
Managed Care March 2007 Louis W. Hutchison |
Unable to Carry Cost Burden, Payers Seek Other Remedies The pharmacy benefit landscape of today is all but unrecognizable from its predecessor of just a decade ago. Blending an approach that uses education, reward, and penalty can rein in runaway health care costs |
The Motley Fool February 23, 2006 Stephen D. Simpson |
Express Scripts Overdue for a Pause This pharmacy benefits manager is posting very good growth and has room for improvement, but what about the stock price? |
InternetNews February 9, 2010 |
Nvidia Optimus Allows Easy Graphics Switching Switching from integrated to discrete laptop graphics usually meant a reboot. Most people never bothered. So Nvidia did something about it. |
Managed Care December 2003 Tony Berberabe |
Why Do FEHBP and Big Unions Excel at Managing Drug Costs? Pharmacy benefit managers can do only so much to keep drug price increases in the single digits. Initiatives instituted by health plans can help in this effort. |
The Motley Fool August 24, 2010 David Meier |
Can Express Scripts Produce Big Returns? Express Scripts generates incredible returns on equity. Let's see how they do it. |
InternetNews January 29, 2008 Sean Michael Kerner |
Juniper Makes The Switch After 12 years, Juniper finally enters the switch business. |
CFO March 1, 2012 David McCann |
Companies May Win This Drug War The conflict between Express Scripts and Walgreen just might lead to lower drug-benefit costs for companies. |
The Motley Fool July 25, 2011 Brian Orelli |
Express-Medco: Just What the Doctor Prescribed In perhaps the most obviously beneficial merger ever, Express Scripts announced its plan to buy Medco Health Solutions for $29.1 billion. |
Pharmaceutical Executive March 1, 2007 George Koroneos |
Marketing to Professionals: The Formulary Rebound Marketers' professional strategies often fall on deaf ears when there is a cheap alternative available. Here are some tactics that make your brand heard. |
The Motley Fool July 29, 2004 Brian Gorman |
Express Scripts' Bad Day Express Scripts joins other pharmacy benefit managers (PBM) embroiled in legal controversy. But the company, and its competitors, will eventually emerge from the fray and their stocks may then be worth another look. |
Managed Care June 2006 Martin Sipkoff |
Limiting Access to SSRIs Does More Harm Than Good Despite the higher costs of SSRIs, compared to older antidepressants, limiting members' access can lead to undertreated depression. |
Managed Care February 2007 |
Study: Copayments do Affect Compliance Managed care decision makers have a powerful tool that affects patient compliance with antihypertensive medications - the copayment level. |
Managed Care September 2005 |
Plans Continue to Raise Copayments Insurers and employers are passing more and more health care costs along to members. But how much have pharmacy copayments risen? |